Clinical Trial Update: Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy and rituximab with pegfilgrastim followed by rituximab in large B-cell non-Hodgkin's lymphoma has completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large B-cell Non-hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Pegfilgrastim (pegfilgrastim)
• Rituximab (rituximab)
• Undisclosed chemotherapy regimen

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Non-Hodgkins Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2014-02-21